TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22348388

Group type: EXPERIMENTAL
Intervention: AFXL-PDT
Number of subjects: 15

Group type: COMPARATOR
Intervention: PDT
Number of subjects: 15
Study: 19056853

Group type: EXPERIMENTAL
Intervention: Treadmill practice (moving treadmill)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonmoving treadmill (control)
Number of subjects: 24
Study: 18073337

Group type: EXPERIMENTAL
Intervention: Behavioral intervention program promoting healthy eating and physical activity
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baseline survey
Number of subjects: 18
Study: 16926933

Group type: EXPERIMENTAL
Intervention: Palm PDA with angina diagnosis software
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 18
Study: 12027338

Group type: EXPERIMENTAL
Intervention: Goal-setting group (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n = 50)
Number of subjects: 100
Study: 10491058

Group type: EXPERIMENTAL
Intervention: Topical application of strontium salts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 7742579

Group type: EXPERIMENTAL
Intervention: CsA only
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CsA + MP
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CsA + MP + Aza
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: sIL-2R levels increase
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: sIL-2R levels
Number of subjects: 43
Study: 2073001

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg b.i.d.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 7466512

Group type: EXPERIMENTAL
Intervention: Stellenbosch valve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other anaesthetic scavenging devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 31287117

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice (2 cups daily for 12 weeks)
Number of subjects: 37
Study: 28400341

Group type: EXPERIMENTAL
Intervention: TGP plus acitretin
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo plus acitretin
Number of subjects: 108
Study: 25701801

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Waiting-list Control (WLC)
Number of subjects: 34
Study: 24131320

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study: 21389144

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme supplementation (Creon Forte, 100,000 IU lipase)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 19924586

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17901383

Group type: EXPERIMENTAL
Intervention: TENS+TRT
Number of subjects: 88

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo TENS+TRT
Number of subjects: 88

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 88
Study: 15779677

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10686535

Group type: EXPERIMENTAL
Intervention: Cladribine (exact dosage and duration not available)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferons (exact dosage and duration not available)
Number of subjects: 0
Study: 9296731

Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin use (including folic acid, vitamin B12, vitamin B6, vitamin C, and zinc)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivitamin consumption including 0.8 mg folic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin-rich diet, vitamin supplementation, food fortification with vitamins
Number of subjects: 0
Study: 1592976

Group type: EXPERIMENTAL
Intervention: Dentifrice formulations containing NaF, xylitol, or NaF/xylitol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 0
Study: 6731772

Group type: EXPERIMENTAL
Intervention: Midazolam 0.07 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam 0.12 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 30275698

Group type: EXPERIMENTAL
Intervention: Eplerenone 50 mg daily
Number of subjects: 2698

Group type: EXPERIMENTAL
Intervention: Eplerenone 100 mg daily
Number of subjects: 2698

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2698

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2698

Group type: COMPARATOR
Intervention: Active-control
Number of subjects: 2698
Study: 27434476

Group type: EXPERIMENTAL
Intervention: Autologous microsliced modified cartilage perichondrium shield graft
Number of subjects: 51

Group type: COMPARATOR
Intervention: Autologous temporalis muscle fascia graft
Number of subjects: 51
Study: 24643639

Group type: EXPERIMENTAL
Intervention: JET combination therapy
Number of subjects: 288
Study: 22207105

Group type: EXPERIMENTAL
Intervention: Osteopontin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group I (normal epithelia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group II (degenerated epithelia)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithogenic diet group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal diet group
Number of subjects: 0
Study: 20518938

Group type: EXPERIMENTAL
Intervention: Fibre-reinforced posts (FRPs) pretreated
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Fibre-reinforced posts (FRPs) untreated
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Long threaded metal posts (TMPs)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Long (10 mm) pretreated FRP
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Cementation with adhesive resin cement
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (intact natural crowns)
Number of subjects: 144
Study: 18461010

Group type: EXPERIMENTAL
Intervention: Specific Resistance Training (SRT)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: All-round Physical Exercise (APE)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Reference Intervention (REF)
Number of subjects: 549
Study: 15702515

Group type: EXPERIMENTAL
Intervention: Rizatriptan nasal spray (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral rizatriptan tablet (5 mg)
Number of subjects: 0
Study: 12848628

Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg/day for 3 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Prednisolone and Placebo
Number of subjects: 29
Study: 10700887

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy for locally unresectable cancer in the oral cavity, pharynx, and nose and paranasal sinus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy plus adjuvant chemotherapy for advanced N stage nasopharyngeal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy for advanced T stage nasopharyngeal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant and/or concurrent chemoradiotherapy for T2 and T3 laryngeal and hypopharyngeal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin-containing regimens including cisplatin plus 5-fluorouracil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Organ function preservation studies
Number of subjects: 0
Study: 9038610

Group type: EXPERIMENTAL
Intervention: recombinant interleukin-2 (rIL-2) with chemotherapy (5-fluorouracil and leucovorin)
Number of subjects: 17

Group type: COMPARATOR
Intervention: chemotherapy alone
Number of subjects: 17
Study: 1665285

Group type: EXPERIMENTAL
Intervention: Zileuton (A-64077) 600 mg q.i.d. for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of LTB4 levels using RP-HPLC or RIA
Number of subjects: 0
Study: 370894

Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Isopaque Cerebral
Number of subjects: 37
Study: 31144205

Group type: EXPERIMENTAL
Intervention: Chinese Short Warwick‐Edinburgh Mental Well‐being Scale (SWEMWBS)
Number of subjects: 1331
Study: 28511023

Group type: EXPERIMENTAL
Intervention: Lifestyle modification plus DHA-CHO-VE (docosahexaenoic acid, choline, and vitamin E)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle modification plus placebo
Number of subjects: 40
Study: 25529395

Group type: EXPERIMENTAL
Intervention: Pneumonia severity index (PSI)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CURB-65 score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pro-adrenomedullin and pro-atrial natriuretic peptide blood biomarkers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 100
Study: 23072637

Group type: EXPERIMENTAL
Intervention: High-intensity 40 km cycling (morning)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity 40 km cycling (evening)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity 40 km cycling (morning and evening)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity 40 km cycling
Number of subjects: 12
Study: 20957430

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen
Number of subjects: 683

Group type: COMPARATOR
Intervention: Cytosol assays
Number of subjects: 683

Group type: COMPARATOR
Intervention: Immunohistochemistry (IHC)
Number of subjects: 683
Study: 19791640

Group type: EXPERIMENTAL
Intervention: Mastery Motivational Climate (MMC)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Low-Autonomy (LA)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 117
Study: 18035076

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2617

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 2617

Group type: EXPERIMENTAL
Intervention: Early smaller studies
Number of subjects: 2617

Group type: COMPARATOR
Intervention: Occluded Artery Trial and Total Occlusion Study of Canada 2
Number of subjects: 2617
Study: 16649820

Group type: EXPERIMENTAL
Intervention: Quetiapine 600 mg/day
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Quetiapine 300 mg/day
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Quetiapine (pooled doses)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 12414914

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tirofiban
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: eptifibatide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: weight-adjusted heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: oral compounds
Number of subjects: 0
Study: 10400458

Group type: EXPERIMENTAL
Intervention: Antioxidant infusion containing tocopherol and ascorbate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no antioxidant infusion)
Number of subjects: 50
Study: 8524969

Group type: EXPERIMENTAL
Intervention: brotizolam 0.25 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: triazolam 0.25 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo without noise
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo with noise
Number of subjects: 6
Study: 2338695

Group type: EXPERIMENTAL
Intervention: Interval Training Protocol (ITP) - 15 subjects
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Continuous Training Protocol (CTP) - 15 subjects
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control - 12 subjects
Number of subjects: 42
Study: 111286

Group type: EXPERIMENTAL
Intervention: task + reward
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: task + alcohol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: task + reward + alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: task only
Number of subjects: 12
Study: 29273936

Group type: EXPERIMENTAL
Intervention: 11+ Kids warm-up programme
Number of subjects: 3895

Group type: COMPARATOR
Intervention: Usual warm-up
Number of subjects: 3895
Study: 27108817

Group type: EXPERIMENTAL
Intervention: Group I (midazolam, fentanyl, and propofol)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Group II (fentanyl and propofol)
Number of subjects: 140
Study: 23982942

Group type: EXPERIMENTAL
Intervention: Telephone survey administration (n = 99)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Mail with followup telephone call (n = 98)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Mail with followup letter (n = 98)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Survey preference (n = 166)
Number of subjects: 295
Study: 23072847

Group type: EXPERIMENTAL
Intervention: Yoyo Bitters (1206.5 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Yoyo Bitters (804.3 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Yoyo Bitters (various dosages)
Number of subjects: 20
Study: 20397459

Group type: EXPERIMENTAL
Intervention: Warm-moxibustion
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Manual-acupuncture
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study: 18787516

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (N = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal sodium diet (N = 40)
Number of subjects: 80
Study: 16106331

Group type: EXPERIMENTAL
Intervention: Informational audiotapes on self‐care behaviors (SCBs) to manage side effects
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study: 12407324

Group type: EXPERIMENTAL
Intervention: Conventional hormone replacement therapy (HRT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Tibolone
Number of subjects: 6
Study: 10369404

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 122

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 122
Study: 7785477

Group type: EXPERIMENTAL
Intervention: Parent training program for methadone clients
Number of subjects: 0
Study: 2258349

Group type: EXPERIMENTAL
Intervention: Pefloxacin (oral treatment for a mean duration of 13 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Ceftazidime (intravenous treatment for a mean duration of 10 days)
Number of subjects: 67
Study: 6248780

Group type: EXPERIMENTAL
Intervention: Dialyzable transfer factor
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 30674315

Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy BMI and weekly gestational weight gain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly gestational weight gain
Number of subjects: 0
Study: 29284542

Group type: EXPERIMENTAL
Intervention: Medical Index
Number of subjects: 53

Group type: COMPARATOR
Intervention: RETTS‐A
Number of subjects: 53
Study: 26440237

Group type: EXPERIMENTAL
Intervention: IV sildenafil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Group C)
Number of subjects: 0
Study: 22819555

Group type: EXPERIMENTAL
Intervention: lycopene-rich diet (224-350 mg lycopene/week)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: lycopene supplement (70 mg lycopene/week)
Number of subjects: 54

Group type: COMPARATOR
Intervention: control diet (<10 mg lycopene/week)
Number of subjects: 54
Study: 21191379

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) treatment
Number of subjects: 0
Study: 19928658

Group type: EXPERIMENTAL
Intervention: Postoperative group (patients who underwent surgery)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 21
Study: 16905573

Group type: EXPERIMENTAL
Intervention: Continuous negative extrathoracic pressure (CNEP)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Standard respiratory management
Number of subjects: 133
Study: 15249569

Group type: EXPERIMENTAL
Intervention: NVP only
Number of subjects: 894

Group type: COMPARATOR
Intervention: NVP plus ZDV
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: NVP only (for infants not infected at birth)
Number of subjects: 894

Group type: COMPARATOR
Intervention: NVP plus ZDV (for infants not infected at birth)
Number of subjects: 894
Study: 10837284

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Folic acid-fortified breakfast cereals
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Increased consumption of folate-rich foods
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 9345249

Group type: EXPERIMENTAL
Intervention: subliminal MIO stimulus
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: subliminal stimuli (one of three types)
Number of subjects: 74

Group type: COMPARATOR
Intervention: control stimulus
Number of subjects: 74
Study: 8457814

Group type: EXPERIMENTAL
Intervention: Johnson antishear device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard shin pad
Number of subjects: 10
Study: 2938886

Group type: EXPERIMENTAL
Intervention: Combined pill (oral contraceptive)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depot-medroxyprogesterone acetate (DMPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Progestin-only pill
Number of subjects: 0

Group type: COMPARATOR
Intervention: DMPA and progestin-only treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Progestin-only and DMPA groups
Number of subjects: 0
Study: 30032176

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich extract from grape and blueberry (PEGB) 600 mg/day for 6 months
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 30515403

Group type: EXPERIMENTAL
Intervention: High-fat meal ingestion
Number of subjects: 2
Study: 27264945

Group type: EXPERIMENTAL
Intervention: Clonidine 3 µg per kg
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo (equal quantity of saline)
Number of subjects: 380
Study: 24889086

Group type: EXPERIMENTAL
Intervention: Best-corrected vision
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: +2.00 DS blur
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: +3.00 DS blur
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low contrast targets
Number of subjects: 10

Group type: COMPARATOR
Intervention: High contrast targets
Number of subjects: 10
Study: 22226008

Group type: EXPERIMENTAL
Intervention: Intensive glucose-control strategy (aiming for HbA1c ≤6.5%)
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Standard glucose-control strategy
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Comparison of intensive vs standard glucose-control
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Treatment combinations including insulin
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Treatment combinations including thiazolidinediones
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Treatment combinations including sulphonylureas
Number of subjects: 11140
Study: 20855825

Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg
Number of subjects: 736

Group type: COMPARATOR
Intervention: Fulvestrant 250 mg
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg and Fulvestrant 250 mg
Number of subjects: 736
Study: 18470404

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 30

Group type: COMPARATOR
Intervention: Etomidate
Number of subjects: 30
Study: 15844709

Group type: EXPERIMENTAL
Intervention: INF alfacon‐1, 15 microg three times per week, plus ribavirin, 1 g/day
Number of subjects: 128

Group type: COMPARATOR
Intervention: IFN‐alpha2b, 3 million units three times per week, plus ribavirin, 1 g/day
Number of subjects: 128
Study: 12427292

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 128
Study: 11022071

Group type: EXPERIMENTAL
Intervention: Dysport 500 U
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Dysport 1000 U
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Dysport 1500 U
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 8659037

Group type: EXPERIMENTAL
Intervention: Radiation treatment (group 1)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Chemotherapy and estrogens in addition to radiation (group 2)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Drugs and estrogens (group 3)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Partial response
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Morphological examination of transrectal prostatic biopsies
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Long-term outcomes
Number of subjects: 122
Study: 1467075

Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine 10 ml
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Extradural saline 10 ml
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no extradural injection)
Number of subjects: 28
Study: 6329021

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg orally every 6 hours
Number of subjects: 909

Group type: COMPARATOR
Intervention: Conventional alkali therapy
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 909

Group type: COMPARATOR
Intervention: Magnesium trisilicate (control)
Number of subjects: 909
Study: 30901266

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-remitters)
Number of subjects: 0
Study: 28874133

Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg, 3 times daily)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 25963037

Group type: EXPERIMENTAL
Intervention: Positive expectations about infrasound prior to first exposure session
Number of subjects: 64

Group type: COMPARATOR
Intervention: Negative expectations about infrasound prior to first exposure session
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Positive expectations after negative expectations
Number of subjects: 64
Study: 23466656

Group type: EXPERIMENTAL
Intervention: ASD
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: ASD+ADHD
Number of subjects: 92

Group type: COMPARATOR
Intervention: TD
Number of subjects: 92